Mr. Market is wrong on this?Interesting to note the feature they have in SH under peers. A lot of comparables are to companies doing research in cancer treatments (high cost for trials, low chance of success). Looking at relative and intrinsic value and seeing where CZO's market cap is at is a test of one's patience and conviction.The recent financials could easily support a stock price much higher than the current share price.
Collectively insiders do own just under 11% of the shares, and Gilles has exposure to 2.35M shares, Glen Rourke has 1.34M and Don Oborowsky 1.46M. There is enough skin in the game.
This appears to remain a "show me" story or "tell me the story" story. Nonetheless this still has all the potential to be a 10 bagger. Putting this one under the victim of in-efficient markets which allows nimble retail investors to win the stock picker's game in the nano-micro cap space.